Gynecomastia Flashcards
Causes of Neonatal mastauxe
is directly correlated to circulating maternal estrogens, and
is seen in almost 70% of infants
A small breast bud of l to 2 cm is
often palpable in the newborn
T
As maternal estrogen levels fall, some
neonates experience a surge of prolactin, which may cause the temporary secretion of milk
T
during puberty the percentage of transient gynecomastia during this period of development
Up to 65% of adolescent
boys experience transient gynecomastia
An elevated ratio of circulating estradiol to testosterone
during puberty is thought to be causative
T with an onset between
the ages of 10 and 13 years
The percentage of males who have persistent gynecomastia beyond the puberty period?
Approximately 4% of males will have
persistent gynecomastia beyond this period
defined by breast bud enlargement of greater than 4 cm
senile gynecomastia cause?
attributed to decreases in testosterone and
an increase in adipose tissue, leading to the peripheral conversion
of androgens to estrogens
this imbalance of hormones
leads to breast enlargement that affects up to 65% ofmen
T
Nucleoside reverse transcriptase inhibitors can cause gynecomastia
T
softening and dissipation of the glandular breast enlargement should be seen within
1 month of discontinuation of the offending agent
T
The breast bud beneath the nipple areolar
the complex is often painless to the patient with
idiopathic gynecomastia
F is often tender to the patient with
idiopathic gynecomastia
breast cancer must always remain on the differential
diagnosis when examining breast enlargement in male patients
T
In patients with Klinefelter syndrome, their risk of
developing breast cancer is almost 60 times greater than the general
male population,
T excisional surgical techniques are preferred in
this high-risk population.
all of these classification systems focus on the degree of breast enlargement as well as
the skin redundancy and nipple ptosis
T
Nonsurgical management of gynecomastia should be explored first
T
Percentage of patients whom response to tamoxifen
complete resolution of gynecomastia in 83.3% of their
patients treated with tamoxifen
tamoxifen is not
yet approved by the Food and Drug Administration as a treatment
for gynecomastia
T
Clomiphene citrate significantly improves the outcome of gynecomastia
Clomiphene citrate has also been trialed in small
studies, with minimal improvement in the adolescent population
Patients with prostate cancer treated with bicalutamide monotherapy commonly experience gynecomastia and mastodynia how you can treat them ?
receive off-label prophylactic or therapeutic treatment
with tamoxifen or anastrazole, an aromatase inhibitor, with varying
levels of efficacy or Prophylactic radiotherapy
when we can strat the surgical treatment for gynecomastia?
If exogenous causes are controlled and the patient’s gynecomastia
persists for at least 1 year, surgical treatment is warranted
Suction-assisted lipectomy is an excellent option for patients with
minimal to moderate tissue and skin excess
T
The use of ultrasound-assisted liposuction has broadened the
indications for liposuction, as it is able to address the firmer glandular breast tissue under the nipple areolar complex.
T
The IMF should be preserve in patient with gynicomastia
The surgeon
should intentionally disrupt the inframammary fold, because such
dermoglandular attachment is feminizing
the
lower pole may be contoured via liposuction to emphasize the inferior border of the pectoralis major muscle and create more masculine
definition
T
In patients with moderate glandular excess as well as moderate
skin excess it is advisable to stage skin excision by performing liposuction or direct glandular excision first.
T